In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds
et al., Computation, doi:10.3390/computation10040051
, In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
In Silico analysis identifying strong or moderate affinity bindings for ivermectin to multiple sites on the spike protein, CD147 and α7nAChr, which may provide effective competitive binding for all variants of SARS-CoV-2.Ivermectin had the highest affinity to the α7nAChr receptor. Analysis showed a potential direct binding of SARS-CoV-2 spike protein to α7nAChr, suggesting mediation of SARS-CoV-2 cellular entry, and potentially shedding light on aspects of COVID-19 including the loss of smell and taste, cytokine storm, and impairment of endothelium-dependent acetylcholine-induced vasodilation.
Aminpour et al., 25 Mar 2022, peer-reviewed, 12 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.